← Back to headlines
Brown Capital Management Bets on Krystal Biotech for Revenue Stream
The Brown Capital Management Small Company Fund has invested in Krystal Biotech (KRYS), citing the company's resilient revenue stream as a key factor in their decision.
24 Jun, 13:55 — 24 Jun, 13:55
Sources
Showing 1 of 1 sources
Related Stories
Asian Markets Fall and Oil Prices Rise Amid Escalating US-Iran Tensions
1h ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
1h ago
Apple Sets Executive Pay for New CEO John Ternus and Chair Tim Cook
1h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
2h ago